Discuss the significance of expanding notified ports of entry for drug imports in strengthening India's pharmaceutical supply chain. Illustrate with recent examples.

Q. Discuss the significance of expanding notified ports of entry for drug imports in strengthening India's pharmaceutical supply chain. Illustrate with recent examples. (15 marks, 250-350 words)

Rule 43A of the Drugs Rules, 1945 works as a positive list: drugs may lawfully enter India only through ports expressly notified by the Union Health Ministry. Expanding that list is therefore a supply-chain intervention, not a routine administrative act.

Significance for the pharmaceutical supply chain - Redundancy and decongestion: adding Navi Mumbai Airport as the 42nd notified port of entry (July 2026) gives the Mumbai Metropolitan Region a second pharma gateway alongside CSMIA, reducing single-point dependence [1]. - Time- and temperature-sensitivity: vaccines, biologics and blood products lose value with dwell time; shorter clearance routes protect cold-chain integrity. - Input security for the "pharmacy of the world": India's formulation exports rest heavily on imported APIs and intermediates; more entry points cut lead times and landed costs. - Multi-modal spread: the 42 ports cover air, sea, road and rail, so disruption at one mode does not halt medicine imports [1]. - Trade facilitation and ease of doing business, without diluting scrutiny — the amendment was made only after consultation with the Drugs Technical Advisory Board (DTAB) under the Drugs and Cosmetics Act, 1940 [1].

Recent illustrations - Notification of Navi Mumbai Airport followed the operationalisation of NMIA, India's largest greenfield PPP airport, inaugurated in October 2025 [2] — showing regulation sequenced with new infrastructure. - The 2026 amendment simplifying import of small quantities of drugs for examination, test or analysis through an acknowledgement-based intimation replaced licensing, easing R&D imports [3].

A necessary caveat: notification alone is insufficient; a port becomes effective only with adequate CDSCO port-office staffing, testing laboratories and cold-storage capacity.

Expanding notified ports thus converts new transport infrastructure into genuine health-system capacity, marrying trade facilitation with drug-safety oversight. Matching each new port with regulatory manpower and testing facilities would make India's pharmaceutical supply chain both faster and more resilient — advancing affordable access to medicines and SDG-3.

(~320 words)

Sources: 1. Centre permits drug imports through Navi Mumbai Airport — Akashvani News, Prasar Bharati (8 July 2026) — Rule 43A amendment, 42 notified ports, DTAB consultation, trade-facilitation rationale 2. PIB: Prime Minister Shri Narendra Modi inaugurates Navi Mumbai International Airport (8 October 2025) — NMIA operationalisation, greenfield PPP airport 3. PIB: Government Simplifies Procedure for Import of Drugs for Examination, Test or Analysis under Drugs Rules, 1945 — acknowledgement-based import for testing/R&D